Fundamental Data for KG

KING PHARM(NYSE:KG)

King Pharmaceuticals, Inc. is a vertically integrated pharmaceutical company that manufactures, markets and sells primarily branded prescription pharmaceutical products. Through a national sales force they market their branded pharmaceutical products to general/family practitioners, internal medicine physicians, cardiologists, endocrinologists, pediatricians and hospitals across the country.

# Employees: 3392

Address: 501 Fifth Street,Bristol,TN,USA

Phone: 423 989-8000

Fax: 423 274-8677

Website: www.kingpharm.com

Email: Customer_Service@kingpharm.com

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Ted G. Wood (Chrmn.; Presi.; C.E.O.; Dir.)

James E. Green (Exe.V.P.;)

Joseph Squicciarino (C.F.O.)

James W. Elrod (Gener. Consl.)

Earnest W. Deavenport Jr. (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/25/2010

Mean EPS (Next Qtr): $0.24

Mean EPS (Year): $1.11

Mean Estimate(Long Term): $10.08

P/E Ratio(Based on EPS estimate): 10.600

Number of Estimates: 15

Shares Performance

Period	KG	Compare to S&P
YTD	11.11 %	-8.04 %
4 Weeks	13.68 %	12.45 %
12 Weeks	13.35 %	6.87 %

Shares Information

Analyst Coverage: Y

Avg Volume: 3420093

Shares Outstanding: 248M

Market Cap: $2.93B

52 Week High: $11.80

52 Week Low: $6.13

P/E Ratio: 10.630

PEG Ratio: 1.050

Split: On 7/20/2001 KG split by factor of 1.330

Earnings Performance

EPS Growth in Last Quarter: -9.38 %

EPS Growth in Last Year: -12.12 %

Sales Growth in Last Quarter: 4.13 %

Sales Growth in Last Quarter: 19.28 %

Financials

Qtr Book Value: $1.28

Cash Flow/Share: $6.36

Change in Payout Ratio: -0.010

Price/Sales: 1.740